Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
CC transcript
Appointed director
Inv. presentation
Acq. announced
ENDO HEALTH SOLUTIONS INC. (ENDP) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/17/2013 8-K/A Acquisition/merger/asset purchase announced
12/16/2013 8-K Acquisition/merger/asset purchase announced
08/12/2010 8-K Acquisition/merger/asset purchase announced
Docs: "Agreement and Plan of Merger, by and among Endo Pharmaceuticals Holdings Inc., West Acquisition Corp. and Penwest Pharmaceuticals Co",
"AMENDMENT TO THE AMENDED AND RESTATED STRATEGIC ALLIANCE AGREEMENT",
"Form of Shareholder Tender Agreement",
"ENDO PHARMACEUTICALS AGREES TO ACQUIRE PENWEST PHARMACEUTICALS AND SUBMITS NDA FOR NEW FORMULATION OF LONG-ACTING OXYMORPHONE DESIGNED TO BE CRUSH-RESISTANT"
05/07/2010 8-K Acquisition/merger/asset purchase announced
Docs: "Agreement and Plan of Merger, by and among Endo Pharmaceuticals Holdings Inc., HT Acquisition Corp. and HealthTronics, Inc",
"Form of Shareholder Tender Agreement"
03/23/2009 8-K Acquisition/merger/asset purchase announced
Docs: "Supplemental Octreotide CSR Agreement, by and between Endo and the Paying Agent",
"Supplemental Stent CSR Agreement, by and between Endo and the Paying Agent",
"Supplemental Supprelin CSR Agreement, by and between Endo and the Paying Agent",
"Endo Pharmaceuticals Completes Acquisition of Indevus Pharmaceuticals"
02/06/2009 8-K Form 8-K -- Current report
01/07/2009 8-K Acquisition/merger/asset purchase announced
Docs: "Amendment, to the Agreement and Plan of Merger, by and among Endo Pharmaceuticals Holdings Inc., BTB Purchaser Inc. and Indevus Pharmaceuticals, Inc"
01/05/2009 8-K Acquisition/merger/asset purchase announced
Docs: "Agreement and Plan of Merger, by and among Endo, Purchaser, and Indevus",
"Form of Stockholder Tender Agreement",
"Form of NEBIDO® Contingent Cash Consideration Agreement",
"Form of Octreotide Contingent Cash Consideration Agreement",
"Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy